In hypercholesterolemia, adding inclisiran to individually optimized lipid-lowering therapy improved LDL-C levels at 90 d.
Where this comes from
- Record sourced from PubMed, PMID 41490496.
- Also identified by DOI 10.7326/ANNALS-25-05115-JC.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
GIM/FP/GP: [Formula: see text] Cardiology: [Formula: see text].
Medical subject headings
- Hypercholesterolemia
- Cholesterol, LDL
- Anticholesteremic Agents